After the U.S. obliterated some of Iran’s key nuclear sites last summer, the regime continued pursuing nuclear capabilities at unacceptable levels, Trump said.
Lola Olivia Inc. failed to disclose health risks associated with chest binder use and misrepresented the devices as ‘undergarments,’ a district judge wrote.
The FDA began removing a cancer warning in November. Since then, manufacturers have been unable to provide some pharmacies with adequate supplies, CVS reported.
After the U.S. obliterated some of Iran’s key nuclear sites last summer, the regime continued pursuing nuclear capabilities at unacceptable levels, Trump said.
Lola Olivia Inc. failed to disclose health risks associated with chest binder use and misrepresented the devices as ‘undergarments,’ a district judge wrote.
The FDA began removing a cancer warning in November. Since then, manufacturers have been unable to provide some pharmacies with adequate supplies, CVS reported.